Terms: = Germ cell tumor AND MAF, MGC71685, 4094, ENSG00000178573 AND Treatment
8 results:
1. Development of a Macrophage-Related Risk Model for Metastatic Melanoma.
Li Z; Zhang X; Jin Q; Zhang Q; Yue Q; Fujimoto M; Jin G
Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762054
[TBL] [Abstract] [Full Text] [Related]
2. Targeting Melanoma-Associated Fibroblasts (mafs) with Activated γδ (Vδ2) T cells: An In Vitro Cytotoxicity Model.
Hajdara A; Çakır U; Érsek B; Silló P; Széky B; Barna G; Faqi S; Gyöngy M; Kárpáti S; Németh K; Mayer B
Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37629075
[TBL] [Abstract] [Full Text] [Related]
3. Circulating tumor DNA is a prognostic biomarker in metastatic melanoma patients treated with chemoimmunotherapy and BRAF inhibitor.
Mattila KE; Mäkelä S; Kytölä S; Andersson E; Vihinen P; Ramadan S; Skyttä T; Tiainen L; Vuoristo MS; Tyynelä-Korhonen K; Koivunen J; Kohtamäki L; Aittomäki K; Hernberg M
Acta Oncol; 2022 Oct; 61(10):1263-1267. PubMed ID: 36307938
[TBL] [Abstract] [Full Text] [Related]
4. Immune Checkpoints Inhibitors and SRS/SBRT Synergy in Metastatic Non-Small-cell Lung Cancer and Melanoma: A Systematic Review.
Rodríguez Plá M; Dualde Beltrán D; Ferrer Albiach E
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769050
[No Abstract] [Full Text] [Related]
5. Establishment of patient-derived orthotopic xenograft model of 1q+ posterior fossa group A ependymoma.
Pierce AM; Witt DA; Donson AM; Gilani A; Sanford B; Sill M; Van Court B; Oweida A; Prince EW; Steiner J; Danis E; Dorris K; Hankinson T; Handler MH; Jones KL; Karam SD; Serkova NJ; Vibhakar R; Foreman NK; Griesinger AM
Neuro Oncol; 2019 Dec; 21(12):1540-1551. PubMed ID: 31276586
[TBL] [Abstract] [Full Text] [Related]
6. NRL and CRX Define Photoreceptor Identity and Reveal Subgroup-Specific Dependencies in Medulloblastoma.
Garancher A; Lin CY; Morabito M; Richer W; Rocques N; Larcher M; Bihannic L; Smith K; Miquel C; Leboucher S; Herath NI; Dupuy F; Varlet P; Haberler C; Walczak C; El Tayara N; Volk A; Puget S; Doz F; Delattre O; Druillennec S; Ayrault O; Wechsler-Reya RJ; Eychène A; Bourdeaut F; Northcott PA; Pouponnot C
Cancer Cell; 2018 Mar; 33(3):435-449.e6. PubMed ID: 29533784
[TBL] [Abstract] [Full Text] [Related]
7. The two most common histological subtypes of malignant germ cell tumour are distinguished by global microRNA profiles, associated with differential transcription factor expression.
Murray MJ; Saini HK; van Dongen S; Palmer RD; Muralidhar B; Pett MR; Piipari M; Thornton CM; Nicholson JC; Enright AJ; Coleman N
Mol Cancer; 2010 Nov; 9():290. PubMed ID: 21059207
[TBL] [Abstract] [Full Text] [Related]
8. Towards the definition of the best management and prognostic factors of teratoma with malignant transformation: a single-institution case series and new proposal.
Necchi A; Colecchia M; Nicolai N; Piva L; Catanzaro M; Biasoni D; Torelli T; Stagni S; Paolini B; Milani A; Salvioni R
BJU Int; 2011 Apr; 107(7):1088-94. PubMed ID: 20868391
[TBL] [Abstract] [Full Text] [Related]
